Leukemia drug Ponatinib shrinks hypertrophic heart cells in early lab test
A new study combining network pharmacology, molecular docking, and H9C2 cell experiments found that low-dose Ponatinib significantly reduced high-salt-induced hypertrophy ...
A new study combining network pharmacology, molecular docking, and H9C2 cell experiments found that low-dose Ponatinib significantly reduced high-salt-induced hypertrophy ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.